Literature DB >> 20133703

Proliferative lesions and metalloproteinase activity in murine lupus nephritis mediated by type I interferons and macrophages.

Antigoni Triantafyllopoulou1, Claus-Werner Franzke, Surya V Seshan, Giorgio Perino, George D Kalliolias, Meera Ramanujam, Nico van Rooijen, Anne Davidson, Lionel B Ivashkiv.   

Abstract

Glomerulonephritis is a major cause of morbidity in patients with systemic lupus erythematosus. Although substantial progress has been made in the identification of pathogenic triggers that result in autoantibody production, little is known about the pathogenesis of aggressive proliferative processes that lead directly to irreversible glomerular damage and compromise of renal function. In this study, we describe a model of polyinosinic: polycytidylic acid-accelerated lupus nephritis in NZB/W mice that is characterized by severe glomerular proliferative lesions with de novo crescent formation, findings that are linked with decreased survival and adverse outcomes in lupus. Proliferative glomerulonephritis was associated with infiltrating kidney macrophages and renal expression of IFN-inducible genes, matrix metalloproteinases (MMPs), and growth factors. Crescent formation and renal MMP and growth factor expression were dependent on renal macrophages that expressed Il10, MMPs, osteopontin, and growth factors, including Pdgfc and Hbegf. Infiltrating macrophages and renal MMP expression were induced by type I IFN. These findings reveal a role for type I IFNs and alternatively activated macrophages in aggressive proliferative lesions of lupus nephritis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20133703      PMCID: PMC2840310          DOI: 10.1073/pnas.0914902107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  36 in total

1.  Activated renal macrophages are markers of disease onset and disease remission in lupus nephritis.

Authors:  Lena Schiffer; Ramalingam Bethunaickan; Meera Ramanujam; Weiqing Huang; Mario Schiffer; Haiou Tao; Michael P Madaio; Michael M Madaio; Erwin P Bottinger; Anne Davidson
Journal:  J Immunol       Date:  2008-02-01       Impact factor: 5.422

2.  Role of tissue factor in a mouse model of thrombotic microangiopathy induced by antiphospholipid antibodies.

Authors:  Surya V Seshan; Claus-Werner Franzke; Patricia Redecha; Marc Monestier; Nigel Mackman; Guillermina Girardi
Journal:  Blood       Date:  2009-06-17       Impact factor: 22.113

3.  Unique expression of suppressor of cytokine signaling 3 is essential for classical macrophage activation in rodents in vitro and in vivo.

Authors:  Yu Liu; Keith N Stewart; Eileen Bishop; Carylyn J Marek; David C Kluth; Andrew J Rees; Heather M Wilson
Journal:  J Immunol       Date:  2008-05-01       Impact factor: 5.422

4.  Increased glomerular matrix metalloproteinase activity in murine lupus nephritis.

Authors:  Anders A Tveita; Ole P Rekvig; Svetlana N Zykova
Journal:  Kidney Int       Date:  2008-07-02       Impact factor: 10.612

5.  Clinical usefulness of a prognostic score in histological analysis of renal biopsy in patients with lupus nephritis.

Authors:  Shoichiro Kojo; Ken-ei Sada; Mizuho Kobayashi; Mie Maruyama; Yohei Maeshima; Hitoshi Sugiyama; Hirofumi Makino
Journal:  J Rheumatol       Date:  2009-07-31       Impact factor: 4.666

Review 6.  Matrix metalloproteinases and matrix receptors in progression and reversal of kidney disease: therapeutic perspectives.

Authors:  Pierre Ronco; Christos Chatziantoniou
Journal:  Kidney Int       Date:  2008-07-23       Impact factor: 10.612

7.  Evidence of concurrent immunopathological mechanisms determining the pathology of severe lupus nephritis.

Authors:  M M Schwartz; S M Korbet; R S Katz; E J Lewis
Journal:  Lupus       Date:  2009-02       Impact factor: 2.911

8.  Interferon-alpha treatment of female (NZW x BXSB)F(1) mice mimics some but not all features associated with the Yaa mutation.

Authors:  Meera Ramanujam; Philip Kahn; Weiqing Huang; Haiou Tao; Michael P Madaio; Stephen M Factor; Anne Davidson
Journal:  Arthritis Rheum       Date:  2009-04

Review 9.  Exploring the full spectrum of macrophage activation.

Authors:  David M Mosser; Justin P Edwards
Journal:  Nat Rev Immunol       Date:  2008-12       Impact factor: 53.106

Review 10.  Glomerular matrix metalloproteinases and their regulators in the pathogenesis of lupus nephritis.

Authors:  Anders Tveita; Ole Petter Rekvig; Svetlana N Zykova
Journal:  Arthritis Res Ther       Date:  2008-12-01       Impact factor: 5.156

View more
  71 in total

Review 1.  Epidermal growth factor receptor mediates injury in rapidly progressive glomerular disease.

Authors:  Sabine Brandt; Peter R Mertens
Journal:  Int Urol Nephrol       Date:  2012-03-24       Impact factor: 2.370

2.  Btk-specific inhibition blocks pathogenic plasma cell signatures and myeloid cell-associated damage in IFNα-driven lupus nephritis.

Authors:  Arna Katewa; Yugang Wang; Jason A Hackney; Tao Huang; Eric Suto; Nandhini Ramamoorthi; Cary D Austin; Meire Bremer; Jacob Zhi Chen; James J Crawford; Kevin S Currie; Peter Blomgren; Jason DeVoss; Julie A DiPaolo; Jonathan Hau; Adam Johnson; Justin Lesch; Laura E DeForge; Zhonghua Lin; Marya Liimatta; Joseph W Lubach; Sami McVay; Zora Modrusan; Allen Nguyen; Chungkee Poon; Jianyong Wang; Lichuan Liu; Wyne P Lee; Harvey Wong; Wendy B Young; Michael J Townsend; Karin Reif
Journal:  JCI Insight       Date:  2017-04-06

Review 3.  Immunopathology of lupus nephritis.

Authors:  Hans-Joachim Anders; Agnes B Fogo
Journal:  Semin Immunopathol       Date:  2014-01-09       Impact factor: 9.623

Review 4.  Dendritic cells and macrophages in the kidney: a spectrum of good and evil.

Authors:  Natasha M Rogers; David A Ferenbach; Jeffrey S Isenberg; Angus W Thomson; Jeremy Hughes
Journal:  Nat Rev Nephrol       Date:  2014-09-30       Impact factor: 28.314

Review 5.  Biomarkers of lupus nephritis histology and flare: deciphering the relevant amidst the noise.

Authors:  Daniel J Birmingham; Michael Merchant; Sushrut S Waikar; Haikady Nagaraja; Jon B Klein; Brad H Rovin
Journal:  Nephrol Dial Transplant       Date:  2017-01-01       Impact factor: 5.992

6.  Immune gene expression in kidney biopsies of lupus nephritis patients at diagnosis and at renal flare.

Authors:  Juan M Mejia-Vilet; Samir V Parikh; Huijuan Song; Paolo Fadda; John P Shapiro; Isabelle Ayoub; Lianbo Yu; Jianying Zhang; Norma Uribe-Uribe; Brad H Rovin
Journal:  Nephrol Dial Transplant       Date:  2019-07-01       Impact factor: 5.992

7.  Engraftment of peripheral blood mononuclear cells from systemic lupus erythematosus and antiphospholipid syndrome patient donors into BALB-RAG-2-/- IL-2Rγ-/- mice: a promising model for studying human disease.

Authors:  Danieli Andrade; Patricia B Redecha; Milena Vukelic; Xiaoping Qing; Giorgio Perino; Jane E Salmon; Gloria C Koo
Journal:  Arthritis Rheum       Date:  2011-09

8.  IFN-α confers resistance of systemic lupus erythematosus nephritis to therapy in NZB/W F1 mice.

Authors:  Zheng Liu; Ramalingam Bethunaickan; Weiqing Huang; Meera Ramanujam; Michael P Madaio; Anne Davidson
Journal:  J Immunol       Date:  2011-06-24       Impact factor: 5.422

9.  Structure and function of renal macrophages and dendritic cells from lupus-prone mice.

Authors:  Ranjit Sahu; Ramalingam Bethunaickan; Satwinder Singh; Anne Davidson
Journal:  Arthritis Rheumatol       Date:  2014-06       Impact factor: 10.995

Review 10.  Type I interferon: friend or foe?

Authors:  Giorgio Trinchieri
Journal:  J Exp Med       Date:  2010-09-13       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.